We are live on ! Find out more
ALT icon

Altimmune

172 hedge funds and large institutions have $453M invested in Altimmune in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 29

77% more call options, than puts

Call options by funds: $20.6M | Put options by funds: $11.6M

37% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 38

20% more funds holding

Funds holding: 143172 (+29)

18.46% more ownership

Funds ownership: 64.32%82.78% (+18%)

16% more capital invested

Capital invested by funds: $389M → $453M (+$63.9M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
172
Holders Change
+29
Holders Change %
+20.28%
% of All Funds
2.48%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
59
Increased
52
Reduced
38
Closed
29
Calls
$20.6M
Puts
$11.6M
Net Calls
+$8.98M
Net Calls Change
-$3.81M
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$3.15M -$2.42M -237,982 -43%
MAP
27
Moody Aldrich Partners
Massachusetts
$3.13M +$3.13M +307,318 New
TIM
28
Timelo Investment Management
Ontario, Canada
$2.99M -$5.24M -515,000 -64%
VOYA Investment Management
29
VOYA Investment Management
Georgia
$2.93M +$2.72M +267,769 +1,306%
GL
30
Gerber LLC
Ohio
$2.87M +$264K +26,000 +10%
AAP
31
Ardsley Advisory Partners
Connecticut
$2.8M -$671K -66,000 -19%
BWCS
32
Beirne Wealth Consulting Services
Connecticut
$2.78M -$315K -31,000 -10%
GTC
33
Ghost Tree Capital
New York
$2.54M +$2.54M +250,000 New
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$2.39M -$272K -26,788 -10%
WP
35
Woodline Partners
California
$2.18M +$2.18M +214,245 New
SPS
36
Susquehanna Portfolio Strategies
Pennsylvania
$2.11M
Schroder Investment Management Group
37
Schroder Investment Management Group
United Kingdom
$1.94M +$1.94M +190,824 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.93M -$19.7K -1,934 -1%
IMC Chicago
39
IMC Chicago
Illinois
$1.69M +$344K +33,869 +26%
Wellington Management Group
40
Wellington Management Group
Massachusetts
$1.6M +$1.6M +156,914 New
LCM
41
Lynwood Capital Management
Ontario, Canada
$1.53M +$1.53M +150,000 New
Simplex Trading
42
Simplex Trading
Illinois
$1.49M +$825K +81,128 +125%
Charles Schwab
43
Charles Schwab
California
$1.45M
PA
44
Profund Advisors
Maryland
$1.37M +$1.37M +134,842 New
RJA
45
Raymond James & Associates
Florida
$1.23M +$1.23M +121,137 New
CCIA
46
Campbell & Co Investment Adviser
Maryland
$1.12M +$1.12M +110,213 New
PI
47
Pennant Investors
New Jersey
$1.12M
Swiss National Bank
48
Swiss National Bank
Switzerland
$1.08M +$1.08M +106,000 New
OAC
49
OMERS Administration Corp
Ontario, Canada
$1.06M +$1.06M +104,600 New
SAM
50
Silvercrest Asset Management
New York
$1.05M

ALT Hedge Fund Activity: Q1 2024 in Review

172 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q1 2024, worth a combined $453M — up 16% from $389M a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new ALT positions and 29 closed out — a net gain of 30 holders — while 52 added to existing stakes and 38 trimmed.

The largest buyer was State Street, adding an estimated $77.7M. The largest seller was Ameriprise, cutting an estimated $25.2M.

  • 172 institutional investors held Altimmune (ALT) as of Q1 2024, up from 143 in Q4 2023.
  • Funds reported $453M of Altimmune stock for Q1 2024, up 16% quarter-over-quarter.
  • 59 funds opened new Altimmune positions in Q1 2024 and 29 closed out, a net change of +30 holders.
  • The largest Altimmune buyer in Q1 2024 was State Street, an estimated $77.7M added.
  • The largest Altimmune seller in Q1 2024 was Ameriprise, an estimated $25.2M sold.

Based on aggregated 13F filings for Q1 2024.